P3 Health Partners Inc当前公司基本面数据相对稳定,增长潜力稳定。当前估值合理,在生物技术与医疗研究行业排名176/404位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价10.50。中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
P3 Health Partners Inc评分
相关信息
行业排名
176 / 404
全市场排名
315 / 4582
所属行业
生物技术与医疗研究
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
4
位分析师
买入
评级
10.500
目标均价
+105.88%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
P3 Health Partners Inc亮点
亮点风险
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
公司代码PIII
公司P3 Health Partners Inc
CEOCoffman (Aric)
网址https://ir.p3hp.org/
常见问题
P3 Health Partners Inc(PIII)的当前股价是多少?
P3 Health Partners Inc(PIII)的当前股价是 4.120。
P3 Health Partners Inc的股票代码是什么?
P3 Health Partners Inc的股票代码是PIII。
P3 Health Partners Inc股票的52周最高点是多少?
P3 Health Partners Inc股票的52周最高点是14.500。
P3 Health Partners Inc股票的52周最低点是多少?
P3 Health Partners Inc股票的52周最低点是4.270。
P3 Health Partners Inc的市值是多少?
P3 Health Partners Inc的市值是13.46M。
P3 Health Partners Inc的净利润是多少?
P3 Health Partners Inc的净利润为-135.85M。
现在P3 Health Partners Inc(PIII)的股票是买入、持有还是卖出?
根据分析师评级,P3 Health Partners Inc(PIII)的总体评级为买入,目标价格为10.500。
P3 Health Partners Inc(PIII)股票的每股收益(EPS TTM)是多少
P3 Health Partners Inc(PIII)股票的每股收益(EPS TTM)是-41.248。